Latner Thoracic Surgery Research Laboratories, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Am J Transplant. 2019 Dec;19(12):3377-3389. doi: 10.1111/ajt.15550. Epub 2019 Aug 26.
Chronic lung allograft dysfunction (CLAD) limits long-term survival after lung transplant (LT). Ischemia-reperfusion injury (IRI) promotes chronic rejection (CR) and CLAD, but the underlying mechanisms are not well understood. To examine mechanisms linking IRI to CR, a mouse orthotopic LT model using a minor alloantigen strain mismatch (C57BL/10 [B10, H-2 ] → C57BL/6 [B6, H-2 ]) and isograft controls (B6→B6) was used with antecedent minimal or prolonged graft storage. The latter resulted in IRI with subsequent airway and parenchymal fibrosis in prolonged storage allografts but not isografts. This pattern of CR after IRI was associated with the formation of B cell-rich tertiary lymphoid organs within the grafts and circulating autoantibodies. These processes were attenuated by B cell depletion, despite preservation of allograft T cell content. Our observations suggest that IRI may promote B cell recruitment that drives CR after LT. These observations have implications for the mechanisms leading to CLAD after LT.
慢性肺移植物功能障碍(CLAD)限制了肺移植(LT)后的长期生存。缺血再灌注损伤(IRI)促进慢性排斥反应(CR)和 CLAD,但其中的机制尚不清楚。为了研究 IRI 与 CR 之间的联系机制,我们使用了一种主要组织相容性抗原错配的小鼠原位 LT 模型(C57BL/10 [B10,H-2 ]→C57BL/6 [B6,H-2 ])和同种异体移植对照(B6→B6),并对移植物进行了短暂或延长的储存。后者导致 IRI,并随后在延长储存的同种异体移植物中出现气道和实质纤维化,但在同种异体移植物中没有。IRI 后发生这种 CR 模式与移植物内 B 细胞丰富的三级淋巴器官的形成和循环自身抗体有关。尽管同种异体移植物 T 细胞含量保持不变,但 B 细胞耗竭可减轻这些过程。我们的观察结果表明,IRI 可能促进 B 细胞募集,从而导致 LT 后发生 CR。这些观察结果对导致 LT 后 CLAD 的机制具有重要意义。